Isoxsuprine%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hydrochloride

# Isoxsuprine hydrochloride ## Overview Isoxsuprine hydrochloride is a vasodilator that acts primarily on peripheral blood vessels. Its exact mechanism of action is not fully understood but is thought to involve direct relaxation of vascular smooth muscle. ## Primary Indications * Treatment of peripheral vascular disease, including intermittent claudication and Raynaud's phenomenon. * (Historically) To reduce premature labor, though this use is no longer recommended or approved due to safety concerns and lack of efficacy. ## Adult Dosing * **Peripheral Vascular Disease:** 10-20 mg orally three to four times daily. Doses may be increased to 40 mg four times daily if necessary. ## Pediatric Dosing * There is no established or recommended pediatric dosing for isoxsuprine hydrochloride. Its use in children is not supported by evidence. ## Dose Adjustments * No specific dose adjustments are typically required for renal or hepatic impairment, but caution may be advised in severe cases. ## Contraindications * Hypersensitivity to isoxsuprine hydrochloride. * Patients with congenital heart disease or other conditions where a rapid drop in blood pressure could be detrimental. ## Adverse Effects * **Common:** Nausea, vomiting, gastrointestinal distress, dizziness, weakness, flushing, headache. * **Less Common/Serious:** Hypotension, tachycardia, rash, paradoxical chest pain, and potential for increased bleeding risk. ## Key Drug Interactions * **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications. * **Anticoagulants/Antiplatelets:** Increased risk of bleeding due to potential additive effects. ## Monitoring * Blood pressure and heart rate. * Signs and symptoms of peripheral vascular disease improvement. * Signs of bleeding. ## Clinical Pearls * Efficacy in treating peripheral vascular disease is controversial and not universally accepted. * Consider alternative therapies with better-established efficacy and safety profiles for peripheral vascular disease. * Avoid use in pregnant patients due to significant safety concerns. *** *Disclaimer: This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for definitive patient management.*